Advance your ocular therapies with the only full-service CRO to offer personalized ophthalmic drug development services that span the entire continuum from discovery and preclinical to clinical trials and post-market follow-up studies.
Whether you need support with anterior or posterior segments, rare ocular diseases, gene therapies, or ophthalmic devices and diagnostics, we know how to optimize your ophthalmic development.
A strategic vision for your ophthalmic program
Rely on our ophthalmic staff’s deep scientific and regulatory experience from delivering more than 100 global, patient-centric ophthalmology clinical trials for emerging biotech companies over the last five years.
Work with renowned vision scientists as part of our more than 30-year relationship with Ocular Services on Demand (OSOD) to handle your preclinical ocular needs and deliver specialized expertise in the ocular surface and anterior and posterior segments.
Enable intelligent patient recruitment with advanced data and increase your efficiencies with our established relationships with more than 2,000 sites globally.
Look no further: Extend your ophthalmic team’s expertise with a full-service collaboration
Experience counts when it comes to placing patients' needs at the forefront of your decisions and ensuring the success of your ophthalmology drug development program. Our expertise and insights at Labcorp have helped advance more than 100 clinical ophthalmology studies over the last five years as we’ve provided flexible solutions for emerging and mid-sized biotech companies.
Get the cross-functional support and customized strategies you need to accelerate development timelines, anticipate and prevent issues and get your ophthalmic therapy into market. Together, our robust partnership can help your team improve patient lives, faster.
Access tailored preclinical solutions
You may need toxicology (GLP and non-GLP), tissue distribution/pharmacokinetics (PK) and pharmacology to support your ophthalmology preclinical research. We understand the unique differences between the ocular surface, anterior segments and posterior segments and can offer our expertise in several ocular disease areas such as glaucoma, dry eye, uveitis, allergies and retinal diseases.
Your preclinical journey can also benefit from our experience in all drug/therapy classes and our OSOD partnership to provide ocular routes of administration for a number of models.
Working with Labcorp for your ophthalmology research also provides your team with access to our full service labs to address any needs for chemistry or bioanalytical services. Discover the difference of our integrated, comprehensive capabilities.
Unique solutions for clinical trials and testing
Our delivery is centered around unique clinical trial and testing solutions that are both patient-centric and flexibly aligned with your program’s needs.
- Accelerate patient recruitment and site identification – Access our de-identified lab results and patient intelligence data to help identify patient clusters to evaluate inclusion/exclusion criteria, pressure-test protocols and help locate patients near proven, experienced investigator sites that are part of our tracked and trusted network.
- Gain scientific and regulatory support – Extend your team’s capabilities with our regulatory and commercial guidance. Count on our extensive experience in assisting both small biotech and large pharmaceutical companies to help you achieve your strategic goals.
- Apply flexible, integrated delivery models – Whether you need to apply decentralized clinical trial approaches to mitigate delivery risks or take advantage of our full service or functional service provider (FSP) models, we can work together to optimize your delivery.
We design our delivery capabilities to match your preference and the needs of your project. Take advantage of these comprehensive full-service solutions while we track your project’s milestones and data with our Xcellerate® Informatics Suite.